{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T16:43:42Z","timestamp":1793551422664,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.eclinm.2025.103500","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T09:43:44Z","timestamp":1758620624000},"page":"103500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Efficacy and safety of anamorelin for cancer cachexia in patients with unresectable or recurrent gastric cancer: a multicentre, open-label, randomised controlled trial"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7645-2412","authenticated-orcid":false,"given":"Kazuyoshi","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8123-687X","authenticated-orcid":false,"given":"Yasuhiro","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Omori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Yanagimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Shinno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-1096","authenticated-orcid":false,"given":"Ryohei","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Akamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9060-282X","authenticated-orcid":false,"given":"Jin","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eclinm.2025.103500_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103500_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern cooperative oncology Group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103500_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103500_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103500_bib5","first-page":"129","article-title":"Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study","volume":"21","author":"Garcia","year":"2013","journal-title":"Support Care Cancer"},{"issue":"6762","key":"10.1016\/j.eclinm.2025.103500_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"issue":"6817","key":"10.1016\/j.eclinm.2025.103500_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35051587","article-title":"A role for ghrelin in the central regulation of feeding","volume":"409","author":"Nakazato","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103500_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-149-9-200811040-00003","article-title":"Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial","volume":"149","author":"Nass","year":"2008","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.eclinm.2025.103500_bib9","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.CIR.0000127956.43874.F2","article-title":"Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells","volume":"109","author":"Li","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103500_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.eclinm.2025.103500_bib11","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi","year":"2019","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103500_bib12","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.surg.2005.11.015","article-title":"Ghrelin reduction after esophageal substitution and its correlation to postoperative body weight loss in esophageal cancer patients","volume":"139","author":"Doki","year":"2006","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103500_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81195-3","article-title":"Early administration of anamorelin improves cancer cachexia in gastrointestinal cancer patients: an observational study","volume":"14","author":"Matsumoto","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103500_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103500_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1089\/chi.2022.0084","article-title":"Accuracy and precision of opportunistic measures of body composition from the Tanita DC-430U","volume":"19","author":"Parker","year":"2023","journal-title":"Child Obes"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103500_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0885-3924(99)00138-4","article-title":"Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients","volume":"19","author":"Okuyama","year":"2000","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103500_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/(SICI)1099-1611(199907\/08)8:4<355::AID-PON401>3.0.CO;2-I","article-title":"Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy","volume":"8","author":"Kurihara","year":"1999","journal-title":"Psychooncology"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103500_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1023\/A:1015614505929","article-title":"The quality of life questionnaire for cancer patients treated with anticancer drugs (QOL-ACD): validity and reliability in Japanese patients with advanced non-small-cell lung cancer","volume":"11","author":"Matsumoto","year":"2002","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103500_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103500_bib20","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10120-016-0683-4","article-title":"Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer","volume":"20","author":"Yamamoto","year":"2017","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.eclinm.2025.103500_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clnesp.2024.12.024","article-title":"Changes in nutritional status and effectiveness of the dietary intervention of multimodal prehabilitation for patients with colorectal cancer: a secondary analysis of the PREHAB randomized clinical trial","volume":"65","author":"van Erven","year":"2025","journal-title":"Clin Nutr ESPEN"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103500_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7170","article-title":"Real-world safety and effectiveness of anamorelin for cancer cachexia: interim analysis of post-marketing surveillance in Japan","volume":"13","author":"Takayama","year":"2024","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103500_bib23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1164\/rccm.200310-1404OC","article-title":"Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease","volume":"170","author":"Itoh","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103500_bib24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s10120-025-01637-3","article-title":"Effect of anamorelin on body weight in patients with gastric cancer-associated cachexia: an observational study","volume":"28","author":"Yanagimoto","year":"2025","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103500_bib25","first-page":"118","article-title":"Investigation of the association between therapeutic effectiveness of anamorelin and Glasgow prognostic score in patients with cancer cachexia: a competing risk analysis","volume":"43","author":"Shimomura","year":"2025","journal-title":"Invest New Drugs"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103500_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13732","article-title":"Anamorelin efficacy in non-small-cell lung cancer patients with cachexia: insights from ROMANA 1 and ROMANA 2","volume":"16","author":"Laird","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103500_bib27","article-title":"Desensitizing effect of cancer cachexia on immune checkpoint inhibitors in patients with advanced NSCLC","volume":"1","author":"Miyawaki","year":"2020","journal-title":"JTO Clin Res Rep"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103500_bib28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.21873\/anticanres.16188","article-title":"The latest treatments for cancer cachexia: an overview","volume":"43","author":"Watanabe","year":"2023","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103500_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1200\/JCO.1993.11.1.152","article-title":"Body-composition changes in patients who gain weight while receiving megestrol acetate","volume":"11","author":"Loprinzi","year":"1993","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103500_bib30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3892\/ol.2023.14049","article-title":"Role of growth differentiation factor 15 in cancer cachexia (Review)","volume":"26","author":"Ling","year":"2023","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103500_bib31","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1038\/s41467-023-39817-3","article-title":"Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment","volume":"14","author":"Haake","year":"2023","journal-title":"Nat Commun"},{"issue":"24","key":"10.1016\/j.eclinm.2025.103500_bib32","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103500_bib33","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","article-title":"Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice","volume":"26","author":"Suriben","year":"2020","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103500_bib34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamasurg.2018.1645","article-title":"Effect of exercise and nutrition prehabilitation on functional capacity in esophagogastric cancer surgery: a randomized clinical trial","volume":"153","author":"Minnella","year":"2018","journal-title":"JAMA Surg"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702500433X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258953702500433X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T21:28:18Z","timestamp":1771536498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258953702500433X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":34,"alternative-id":["S258953702500433X"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103500","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of anamorelin for cancer cachexia in patients with unresectable or recurrent gastric cancer: a multicentre, open-label, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103500"}}